Homocystinuria due to defect in methylation cbl e

Homocystinuria due to defect in methylation (cblE) is a rare genetic disorder affecting the body's ability to process certain parts of proteins properly. This condition is one of several forms of homocystinuria, which are characterized by high levels of an amino acid called homocysteine in the blood. The cblE type is specifically caused by mutations in the MTRR gene, which plays a crucial role in the methylation process of homocysteine to methionine, an essential amino acid. This article provides an overview of the condition, including its causes, symptoms, diagnosis, and treatment options.

Causes

Homocystinuria due to defect in methylation (cblE) is caused by mutations in the MTRR gene. This gene provides instructions for making an enzyme necessary for the regeneration of another enzyme called methionine synthase. Methionine synthase is critical for the conversion of homocysteine to methionine. When there are mutations in the MTRR gene, this process is disrupted, leading to an accumulation of homocysteine and a deficiency of methionine in the body.

Symptoms

The symptoms of cblE type homocystinuria can vary widely among affected individuals. They may include:

• Developmental delay
• Intellectual disability
• Difficulty walking
• Visual problems, such as nearsightedness (myopia) and dislocation of the lens of the eye
• Thrombosis (blood clots)
• Skeletal abnormalities, such as osteoporosis and a tall, thin body shape
• Megaloblastic anemia

Diagnosis

Diagnosis of homocystinuria due to defect in methylation (cblE) typically involves a combination of biochemical tests and genetic testing. Biochemical tests can detect elevated levels of homocysteine in the blood and urine, as well as reduced levels of methionine. Genetic testing can identify mutations in the MTRR gene, confirming the diagnosis.

Treatment

Treatment for cblE type homocystinuria focuses on managing symptoms and preventing complications. It may include:

• Supplementation with vitamin B12 (cobalamin), which can help reduce homocysteine levels
• A diet low in methionine and supplemented with betaine, another compound that helps reduce homocysteine levels
• Regular monitoring for and treatment of complications, such as thrombosis and osteoporosis

Prognosis

The prognosis for individuals with homocystinuria due to defect in methylation (cblE) varies. Early diagnosis and treatment can improve the quality of life and reduce the risk of complications. However, the condition can be life-threatening if not properly managed.

Homocystinuria due to defect in methylation cbl e Resources
Latest articles Most recent articles Ongoing trials	Wikipedia